| Synonyms: | |
| Status: | Approved (1991) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent Prodrug |
| ATC: | C09AA07 |
| UNII: | UDM7Q7QWP8 |
| InChI Key | XPCFTKFZXHTYIP-PMACEKPBSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H28N2O5 |
| Molecular Weight | 424.5 |
| AlogP | 2.57 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 95.94 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 31.0 |
| Primary Target | |
|---|---|
| Angiotensin-converting enzyme |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Metallo protease
Metallo protease MAE clan
Metallo protease M2 family
|
- | 2-212 | - | - | 16-100 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus | 3 | D003920 | ClinicalTrials |
| Hypertension | 3 | D006973 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 3 | D003924 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Atherosclerosis | 3 | D050197 | ClinicalTrials |
| Nephritis, Hereditary | 2 | D009394 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 86541-75-5 |
| ChEBI | 3011 |
| ChEMBL | CHEMBL838 |
| DrugBank | DB00542 |
| DrugCentral | 299 |
| EPA CompTox | DTXSID5022645 |
| FDA SRS | UDM7Q7QWP8 |
| Human Metabolome Database | HMDB0014682 |
| Guide to Pharmacology | 6374 |
| KEGG | C06843 |
| PharmGKB | PA448561 |
| PubChem | 5362124 |
| SureChEMBL | SCHEMBL16396 |
| ZINC | ZINC000003781943 |